DVA Quote, Financials, Valuation and Earnings

Healthcare Services Group, Inc. has a net margin of 8.45% compared to DaVita, Inc.'s net margin of 9.25%. DaVita, Inc.'s return on equity of 67.52% beat Healthcare Services Group, Inc.'s return on equity of 8.02%.

DaVita, Inc. has a consensus price target of $143.00, signalling upside risk potential of 6.14%. On the other hand Healthcare Services Group, Inc. has an analysts' consensus of $21.50 which suggests that it could grow by 11.75%. Given that Healthcare Services Group, Inc. has higher upside potential than DaVita, Inc., analysts believe Healthcare Services Group, Inc. is more attractive than DaVita, Inc..

DaVita, Inc. has a beta of 0.994, which suggesting that the stock is 0.558% less volatile than S&P 500. In comparison Healthcare Services Group, Inc. has a beta of 0.746, suggesting its less volatile than the S&P 500 by 25.446%.

DaVita, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Healthcare Services Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. DaVita, Inc. pays -- of its earnings as a dividend. Healthcare Services Group, Inc. pays out -- of its earnings as a dividend.

DaVita, Inc. quarterly revenues are $3.6B, which are larger than Healthcare Services Group, Inc. quarterly revenues of $464.3M. DaVita, Inc.'s net income of $306M is higher than Healthcare Services Group, Inc.'s net income of $43M. Notably, DaVita, Inc.'s price-to-earnings ratio is 13.60x while Healthcare Services Group, Inc.'s PE ratio is 35.60x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DaVita, Inc. is 0.75x versus 0.78x for Healthcare Services Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Moderna, Inc. has a net margin of 8.45% compared to DaVita, Inc.'s net margin of -19.69%. DaVita, Inc.'s return on equity of 67.52% beat Moderna, Inc.'s return on equity of -30.18%.

DaVita, Inc. has a consensus price target of $143.00, signalling upside risk potential of 6.14%. On the other hand Moderna, Inc. has an analysts' consensus of $38.80 which suggests that it could fall by -8.06%. Given that DaVita, Inc. has higher upside potential than Moderna, Inc., analysts believe DaVita, Inc. is more attractive than Moderna, Inc..

DaVita, Inc. has a beta of 0.994, which suggesting that the stock is 0.558% less volatile than S&P 500. In comparison Moderna, Inc. has a beta of 1.318, suggesting its more volatile than the S&P 500 by 31.821%.

DaVita, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Moderna, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. DaVita, Inc. pays -- of its earnings as a dividend. Moderna, Inc. pays out -- of its earnings as a dividend.

DaVita, Inc. quarterly revenues are $3.6B, which are larger than Moderna, Inc. quarterly revenues of $1B. DaVita, Inc.'s net income of $306M is higher than Moderna, Inc.'s net income of -$200M. Notably, DaVita, Inc.'s price-to-earnings ratio is 13.60x while Moderna, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DaVita, Inc. is 0.75x versus 7.32x for Moderna, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Option Care Health, Inc. has a net margin of 8.45% compared to DaVita, Inc.'s net margin of 3.61%. DaVita, Inc.'s return on equity of 67.52% beat Option Care Health, Inc.'s return on equity of 15.16%.

DaVita, Inc. has a consensus price target of $143.00, signalling upside risk potential of 6.14%. On the other hand Option Care Health, Inc. has an analysts' consensus of $39.82 which suggests that it could grow by 16.91%. Given that Option Care Health, Inc. has higher upside potential than DaVita, Inc., analysts believe Option Care Health, Inc. is more attractive than DaVita, Inc..

DaVita, Inc. has a beta of 0.994, which suggesting that the stock is 0.558% less volatile than S&P 500. In comparison Option Care Health, Inc. has a beta of 0.842, suggesting its less volatile than the S&P 500 by 15.789%.

DaVita, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Option Care Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. DaVita, Inc. pays -- of its earnings as a dividend. Option Care Health, Inc. pays out -- of its earnings as a dividend.

DaVita, Inc. quarterly revenues are $3.6B, which are larger than Option Care Health, Inc. quarterly revenues of $1.4B. DaVita, Inc.'s net income of $306M is higher than Option Care Health, Inc.'s net income of $51.8M. Notably, DaVita, Inc.'s price-to-earnings ratio is 13.60x while Option Care Health, Inc.'s PE ratio is 27.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DaVita, Inc. is 0.75x versus 1.02x for Option Care Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Surgery Partners, Inc. has a net margin of 8.45% compared to DaVita, Inc.'s net margin of 3.08%. DaVita, Inc.'s return on equity of 67.52% beat Surgery Partners, Inc.'s return on equity of 0.65%.

DaVita, Inc. has a consensus price target of $143.00, signalling upside risk potential of 6.14%. On the other hand Surgery Partners, Inc. has an analysts' consensus of $25.45 which suggests that it could grow by 79.01%. Given that Surgery Partners, Inc. has higher upside potential than DaVita, Inc., analysts believe Surgery Partners, Inc. is more attractive than DaVita, Inc..

DaVita, Inc. has a beta of 0.994, which suggesting that the stock is 0.558% less volatile than S&P 500. In comparison Surgery Partners, Inc. has a beta of 1.975, suggesting its more volatile than the S&P 500 by 97.487%.

DaVita, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Surgery Partners, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. DaVita, Inc. pays -- of its earnings as a dividend. Surgery Partners, Inc. pays out -- of its earnings as a dividend.

DaVita, Inc. quarterly revenues are $3.6B, which are larger than Surgery Partners, Inc. quarterly revenues of $821.5M. DaVita, Inc.'s net income of $306M is higher than Surgery Partners, Inc.'s net income of $25.3M. Notably, DaVita, Inc.'s price-to-earnings ratio is 13.60x while Surgery Partners, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DaVita, Inc. is 0.75x versus 0.55x for Surgery Partners, Inc.. Usually stocks with elevated PS ratios are considered overvalued.